Interpace Biosciences (IDXG) Employee Count
Price: $2.005
Market Cap: $8.83M
Avg Volume: 7.93K
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Interpace Biosciences (IDXG) Employee Count and Revenue Per Employee
How many employees does Interpace Biosciences have?
As of December 31, 2023, Interpace Biosciences has -0.00B employees.
Source: 10-K filed on 2024-04-01
What is Interpace Biosciences's revenue per employee?
Based on the latest data, Interpace Biosciences's revenue per employee is $365.58K.
Source: FY 2023 Financial Report
This figure is calculated by dividing the annual revenue ($40.21M) by the number of employees (-0.00B).
These metrics provide a snapshot of Interpace Biosciences's size in terms of workforce and its ability to generate revenue. The revenue per employee figure can be used as one indicator of the company's operational efficiency.
Current Employee Count
-0.00B
Revenue Per Employee
$365.58K
Historical Employee Count
Historical Revenue Per Employee
Interpace Biosciences Historical Employee Count
The table below shows the employee count for each year, with the latest data available for the last fiscal year 2023.
| Year | Employee Count | Employee % Change | Revenue | Revenue Per Employee | RPE % Change |
|---|---|---|---|---|---|
| 2023 | -0.00B | 17.02% | $40.21M | $365.58K | 7.94% |
| 2022 | -0.00B | -36.05% | $31.84M | $338.70K | 20.51% |
| 2021 | -0.00B | -3.29% | $41.31M | $281.05K | 31.86% |
| 2020 | -0.00B | -13.64% | $32.40M | $213.14K | 55.79% |
| 2019 | -0.00B | 97.75% | $24.08M | $136.81K | -44.39% |
| 2018 | -0.00B | 18.67% | $21.90M | $246.02K | 16.07% |
| 2017 | -0.00B | 22.95% | $15.90M | $211.96K | -1.19% |
| 2016 | -0.00B | -6.15% | $13.09M | $214.51K | 47.83% |
| 2015 | -0.00B | -94.24% | $9.43M | $145.11K | 36.60% |
| 2014 | 1.13K | 36.02% | $119.94M | $106.23K | -41.55% |
| 2013 | -0.00B | -30.49% | $150.84M | $181.74K | 71.00% |
| 2012 | 1.19K | 37.24% | $126.90M | $106.28K | -41.21% |
| 2011 | -0.00B | -43.87% | $157.29M | $180.79K | 93.73% |
| 2010 | 1.55K | 29.17% | $144.65M | $93.32K | 31.95% |
| 2009 | 1.20K | 9.09% | $84.87M | $70.73K | -30.86% |
| 2008 | 1.10K | 0.00% | $112.53M | $102.30K | -3.93% |
| 2007 | 1.10K | 0.00% | $117.13M | $106.48K | -51.04% |
| 2006 | 1.10K | -60.71% | $239.24M | $217.49K | 90.65% |
| 2005 | 2.80K | -10.83% | $319.42M | $114.08K | -1.71% |
| 2004 | 3.14K | -19.16% | $364.44M | $116.06K | 42.01% |
| 2003 | 3.88K | 11.55% | $317.45M | $81.73K | 0.20% |
| 2002 | 3.48K | -29.84% | $284.01M | $81.57K | -41.89% |
| 2001 | 4.96K | - | $696.58M | $140.36K | - |